Stepan CEO Says Fourth-Quarter Volume Growth Will Slow After 6% And 7% Gains
Luis Rojo told analysts to average the second and third quarters, as adjusted EBITDA hit $66 million in the third.
Stepan CEO Luis Rojo said on the company's third-quarter earnings call Wednesday that management is "expecting a lower growth in Q4 for sure," after organic volume rose 6% in the second quarter and 7% in the third. Stepan, which makes specialty and intermediate chemicals that other manufacturers use in end products, posted third-quarter adjusted EBITDA of $66 million, up 18% from a year earlier.
Average the two quarters
Pressed by an analyst from Seaport Research Partners on last quarter's warning of customer pre-buying, Rojo said the earlier estimate of a $5 million to $10 million impact was partly about volume and largely about margin. Second-quarter growth, he said, came "with lower cost inventory in our tank," while the third quarter had a different mix and a normalized cost position.
His advice was to look at both quarters together. "When you think about the 75 and the 66, there was some swing for sure," he said, but "$140 million in those two quarters" showed the discipline of the execution plan.
For the first nine months, he said, organic volume is up 4% in markets growing "0% to 1%." He credited new customers and share gains, and called 4% for the year "outstanding" if it holds.
Costs, savings and a US turnaround
Rojo said fourth-quarter results will carry maintenance and turnaround costs at the company's US phthalic anhydride facility. A mandated turnaround at the Germany polymers site cost about $2 million in the third quarter, Chief Financial Officer Ruben Velasquez said. Rojo said last quarter's guide was $4 million to $5 million of turnaround headwinds across Germany and the US.
Project Catalyst, Stepan's cost-cutting program, is now running ahead of plan, Rojo said: 2026 savings of $66 million to $70 million against the 60 million target, with a third-quarter run rate of about $23 million. He expects to beat $25 million a quarter on average in 2027. Stepan's fixed cost base is roughly $800 million, and he told analysts to factor in 2% to 3% inflation on top of those savings.
Third-quarter numbers
Adjusted earnings were $0.94 per diluted share, up from $0.48, and net income was $17.8 million, up 64%. Surfactant sales rose 15% to $487 million and polymer sales 24% to $179 million, largely on passing through higher raw material costs. Net leverage improved to 2.4 times, and free cash flow was $8 million. Stepan raised its quarterly dividend by $0.01, or 2.5%.
Stepan shares rose about 4% to $67.64 in Wednesday trading.
Rojo said management expects full-year adjusted EBITDA growth, positive free cash flow and further deleveraging in 2026.
Sources
- Stepan Co. (SCL) Beats Q3 Earnings and Revenue Estimates — Yahoo Finance
- Stepan Non-GAAP EPS of $0.94 beats by $0.22, revenue of $692.15M beats by $57.85M | Seeking Alpha — seekingalpha.com
- Stepan Maintains Royal Dividend Status With 2.5% Payout Boost — MarketWatch
- Stepan Reports Third Quarter 2026 Results — prnewswire.com